HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment

Abstract Approximately a half of breast tumors classified as HER2-negative exhibit HER2-low-positive expression. We recently described a high instability of HER2-low-positive expression from primary breast cancer (BC) to relapse. Previous studies reporting discordance in HER2 status between baseline...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Matteo Fassan, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Vernaci, Ottavia Amato, Francesca Porra, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
格式: Artigo
語言:Inglês
出版: Nature Portfolio 2022-05-01
叢編:npj Breast Cancer
在線閱讀:https://doi.org/10.1038/s41523-022-00434-w
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍